Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Amplicon DNA-sequencing of time series of pooled-CRISPR knock-out screens of colon cancer cell lines

ABSTRACT: This project aims to compare gRNA design algorithms using a benchmark CRISPR-knockout library composed of gRNAs targeting essential and non-essential genes.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER:

PROVIDER: E-MTAB-13976 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP159126

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Amplicon DNA-sequencing of time series of pooled-CRISPR knock-out screens of Osimertinib and DMSO-treated cell lines

Project description:This project is a drug-gene interaction CRISPR screen to compare a 3-guide and a 6-guide library.

2025-02-12 | E-MTAB-13979 | biostudies-arrayexpress

Amplicon DNA-sequencing of time series of pooled-CRISPR knock-out screens of the HT29 colon cancer cell line

Project description:This project also aims to compare gRNA design algorithms using a benchmark CRISPR-knockout library composed of gRNAs targeting essential and non-essential genes.

2025-02-12 | E-MTAB-13977 | biostudies-arrayexpress

Amplicon DNA-sequencing of time series of pooled-CRISPR knock-out screens of Osimertinib and DMSO-treated cell lines using a dual-guide CRISPR library

Project description:This project is a drug-gene interaction dual-guide CRISPR screen using a 3-guide pairs per gene library design.

2025-02-12 | E-MTAB-13980 | biostudies-arrayexpress

Amplicon DNA-sequencing of time series of pooled-CRISPR knock-out screens of cell lines using a dual-guide CRISPR library

Project description:This project aims to compare gRNA design algorithms and single- versus dual-targeting using a benchmark CRISPR-knockout library composed of gRNAs targeting essential and non-essential genes.

2025-02-12 | E-MTAB-13981 | biostudies-arrayexpress

Sequence database choice significantly affects taxonomic and functional metaproteomic results in gut microbiota studies

Project description:Elucidating the role of gut microbiota in physiological and pathological processes has recently emerged as a key research aim in life sciences. In this respect, metaproteomics (the study of the whole protein complement of a microbial community) can provide a unique contribution by revealing which functions are actually being expressed by specific microbial taxa. However, its wide application to gut microbiota research has been hindered by challenges in data analysis, especially related to the choice of the proper sequence databases for protein identification. Here we present a systematic investigation of variables concerning database construction and annotation, and evaluate their impact on human and mouse gut metaproteomic results. We found that both publicly available and experimental metagenomic databases lead to the identification of unique peptide assortments, suggesting parallel database searches as a mean to gain more complete information. Taxonomic and functional results were revealed to be strongly database-dependent, especially when dealing with mouse samples. As a striking example, in mouse the Firmicutes/Bacteroidetes ratio varied up to 10-fold depending on the database used. Finally, we provide recommendations regarding metagenomic sequence processing aimed at maximizing gut metaproteome characterization, and contribute to identify an optimized pipeline for metaproteomic data analysis.

2016-10-10 | PXD004039 | Pride

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis

Project description:We explore whether a low-energy diet intervention for Metabolic dysfunction-associated steatohepatitis (MASH) improves liver disease by means of modulating the gut microbiome. 16 individuals were given a low-energy diet (880 kcal, consisting of bars, soups, and shakes) for 12 weeks, followed by a stepped re-introduction to whole for an additional 12 weeks. Stool samples were obtained at 0, 12, and 24 weeks for microbiome analysis. Fecal microbiome were measured using 16S rRNA gene sequencing. Positive control (Zymo DNA standard D6305) and negative control (PBS extraction) were included in the sequencing. We found that low-energy diet improved MASH disease without lasting alterations to the gut microbiome.

2024-12-31 | E-MTAB-14061 | biostudies-arrayexpress

High-throughput CRISPR screen to identify factors involved in DNA methylation maintenance

Project description:Mouse embryonic stem cells have been modified with a DNA methylation reporter based on the Sprn promoter system published in Stelzer et al. (Cell, 2015). This reporter allows selection by Hygromycin as well as mScarlet expression. The cells were infected with a Lentiviral genome-wide CRISPR/Cas library resulting in the upregulation of Hygromycin/mScarlet when cells lose global DNA methylation.

2022-01-01 | E-MTAB-9126 | biostudies-arrayexpress

Machine learning-based plasma proteomic analysis identifies a novel disease-defining biomarkers

Project description:Recent advances in serum proteomic analysis tools have expanded our understanding of various diseases. To identify a novel disease-specific proteomic markers, we used the high-throughput proximity extension assay (PEA) platform to profile plasma proteins from 62 patients with atopic dermatitis (AD), or ulcerative colitis (UC) and 29 healthy subjects. Differentially expressed protein (DEP) analysis yielded 85 (20 unique) and 99 (14 unique) upregulated proteins in AD and UC, respectively, compared to healthy subjects. We integrated a machine-learning (ML) model and selected 24 proteins to distinguish between the diseases, which accurately predicted disease-defining biomarkers based on distinctive proteomic signatures and disease severity. Correlation analysis with disease severity identified upregulated ML-selected proteins such as CCL13, CCL26, CD70, CDON, LY6D and MMP1 in AD, and ITM2A and REG4 in UC. Among these identified proteins, we suggest CDON, CD70 and LY6D, which had highly correlated expression levels, as AD-specific biomarkers. Thus, our results provide insight into the application of ML algorithms for disease diagnosis, and our model may be expanded to other disease contexts.

2025-03-05 | PAD000005 | Pride

In vivo CRISPR/Cas9 screen to identify candidate therapeutic gene targets to enhance docetaxel efficacy in prostate cancer

Project description:Docetaxel chemotherapy in metastatic prostate cancer offers only a modest survival benefit due to emerging resistance. To identify candidate therapeutic gene targets, we applied a murine prostate cancer orthograft model that recapitulates clinical invasive prostate cancer in a genome-wide CRISPR/Cas9 screen under docetaxel treatment pressure.

2020-10-07 | E-MTAB-9482 | biostudies-arrayexpress

Synergistic on auxin and cytokinin 1 positively regulates growth and attenuates soil pathogen resistance

Project description:Plants as non-mobile organisms constantly integrate varying environmental signals to flexibly adapt their growth and development. Local fluctuations in water and nutrient availability, sudden changes in temperature or other abiotic and biotic stresses can trigger changes in the growth of plant organs. Multiple mutually interconnected hormonal signaling cascades act as essential endogenous translators of these exogenous signals in the adaptive responses of plants. Although the molecular backbones of hormone transduction pathways have been identified, the mechanisms underlying their interactions are largely unknown. Here, using genome wide transcriptome profiling we identify an unknown auxin and cytokinin cross-talk component; SYNERGISTIC ON AUXIN AND CYTOKININ1 (SYAC1), whose expression in roots is strictly dependent on both of these hormonal pathways. We show that SYAC1 is a component of secretory pathway, whose enhanced activity interferes with deposition of cell wall components and can fine-tune organ growth and sensitivity to soil pathogens

2020-05-26 | PXD018159 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data